KOCAA
TMO icon

Knights of Columbus Asset Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Knights of Columbus Asset Advisors’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-962
Closed -$554K – 383
2023
Q1 		$554K Sell
962
-11
-1% -$6.2K 0.05% 264
2022
Q4 		$536K Sell
973
-193
-17% -$102K 0.06% 252
2022
Q3 		$591K Sell
1,166
-76
-6% -$42.5K 0.06% 235
2022
Q2 		$675K Sell
1,242
-30
-2% -$16.5K 0.07% 237
2022
Q1 		$751K Buy
1,272
+28
+2% +$16.1K 0.06% 236
2021
Q4 		$830K Buy
1,244
+10
+0.8% +$6.24K 0.07% 230
2021
Q3 		$705K Buy
1,234
+25
+2% +$13.7K 0.06% 237
2021
Q2 		$610K Sell
1,209
-32
-3% -$15.1K 0.06% 236
2021
Q1 		$566K Sell
1,241
-363
-23% -$173K 0.06% 260
2020
Q4 		$747K Sell
1,604
-283
-15% -$133K 0.08% 260
2020
Q3 		$833K Sell
1,887
-2,304
-55% -$952K 0.1% 246
2020
Q2 		$1.52M Sell
4,191
-274
-6% -$91.8K 0.19% 171
2020
Q1 		$1.27M Sell
4,465
-1,609
-26% -$507K 0.16% 197
2019
Q4 		$1.97M Buy
+6,074
New +$1.84M 0.17% 201

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Knights of Columbus Asset Advisors's TMO Position: Q2 2023 in Review

Knights of Columbus Asset Advisors sold out of Thermo Fisher Scientific (TMO) in Q2 2023, closing a stake of 962 shares — an estimated $554K sold.

Knights of Columbus Asset Advisors first reported a position in TMO in Q4 2019 and held it in 14 quarters. The position peaked at $1.97M in Q4 2019. 2,389 funds tracked by Wall St. Rank hold TMO as of Q2 2023.

  • Knights of Columbus Asset Advisors reported no remaining Thermo Fisher Scientific position as of Q2 2023 after selling out during the quarter.
  • Knights of Columbus Asset Advisors sold 962 Thermo Fisher Scientific shares in Q2 2023, an estimated $554K.
  • Knights of Columbus Asset Advisors first reported a position in Thermo Fisher Scientific in Q4 2019 and held it in 14 quarters.
  • Knights of Columbus Asset Advisors's Thermo Fisher Scientific position peaked at $1.97M in Q4 2019.
  • 2,389 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2023.

Based on Knights of Columbus Asset Advisors's 13F filing for Q2 2023, filed 1 Aug 2023.